Early Neurological Assessment With Pupillometry in Cardiac Arrest During Resuscitation (EASY-CARE)

October 25, 2022 updated by: Simone Maria Zerbi, Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva

EASY CARE Early Neurological Assessment With Pupillometry in Cardiac Arrest During Resuscitation

Easy Care study wants to demonstrate a correlation between intra-CPR infrared quantitative pupillometry and return of spontaneous circulation (ROSC).

Neurological pupil index (NPi) will be used alone and in association with end-tidal CO2.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

At the arrival of medicalised rescue team on the emergency scene, patient will be screened for including criteria. In case of eligibility pupillometry will be collected each eye in the following frame time:

  • T 0: time of enrolling
  • T 1: after first cycle of resuscitation (approximatively 2 minutes following guidelines)
  • T 2 … Tn: every cycle of CPR (or every 2 minutes if intubated patient) bilateral pupillometry will be collected
  • T end: the last pupillometry at ROSC time or death. All pupillometry mesures will be obtained from a technician not trained to interpret NPi index. This to maintain blindness during resuscitation efforts.

Data will be collected in anonymous web-based database passwords protected. For the survivors patients enrolled, data collecting continue in Intensive Care Unit (ICU) as neuroprognostication exams (biomarkers, imaging, neurophysiology). Blind follow up will be obtained from ICU as described in secondary outcome section

Study Type

Observational

Enrollment (Anticipated)

214

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Milano, Italy, 20124
        • Recruiting
        • Agenzia Regionale Emergenza Urgenza - AREU
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

all adults present in the Lombardy region at the time of cardiac arrest.

Description

Inclusion Criteria:

  • Not traumatic cardiac arrest in pre-hospital setting (OHCA)
  • unexpected OHCA
  • Lombardy region territory

Exclusion Criteria:

  • Traumatic Brain injury
  • Cerebrovascular emergecies at computer tomography (CT) scan after hospital admission
  • Peripheral or cortical blindness
  • One or both eyes loss
  • Iris palsy or known peripheral anisocoria
  • No indication for resuscitation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Return of spontaneous circulation (ROSC) prediction
Time Frame: Variable because depends on the cardiac resuscitation manoeuvers lasting usually not more than 45 minutes
We are searching for possible correlation between pupillary reactivity (NPi) collected during resuscitation manoeuvres and ROSC. NPi is a numeric score ranges from 0 (unreactive pupils) and 5 (normal reflex).
Variable because depends on the cardiac resuscitation manoeuvers lasting usually not more than 45 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation of NPi and end tidal CO2 (ETCO2) and ROSC prediction
Time Frame: Variable because depends on the cardiac resuscitation manoeuvers lasting usually not more than 45 minutes

NPi meaning has been described previously, ETCO2 represents the amount of CO2 exhaled during ventilation in course of cardiopulmonary resuscitation. It represent a good indicator of tissues reperfusion.

We suppose that NPi could reflect the brainstem vitality. We want to demonstrate if the association between a well known indicator as ETCO2 and the NPi may emprove the ROSC prediction compared to NPi alone (primary objective).

Variable because depends on the cardiac resuscitation manoeuvers lasting usually not more than 45 minutes
Correlation between NPi and Neurological Outcome as Modified Rankin Scale (mRS)
Time Frame: 1 month, 6 months, 1 year

association between pupillary reactivity (NPi) absence and poor neurological outcome. The outcome will be evaluated in using modified Rankin Scale range from 0 (no symptoms) to 6 (death). We will aggregate the outcome in a dichotomised result as: good outcome (mRS 0-4) and poor outcome (mRS 5-6).

The exams of patients will be performed at 1 month, 6 month (or hospital discharge) and 1 year from ROSC, and at ICU discharge.

The patients exams will be performed with a telephone interview about their fisical condition accordingly to mRS score description.

1 month, 6 months, 1 year
Correlation between NPi trend and ROSC
Time Frame: Variable because depends on the cardiac resuscitation manoeuvers lasting usually not more than 45 minutes
We are searching for a possible correlation between the NPi trend during cardiac pulmonary resuscitation (CPR) and the ROSC. We suppose that an improvement of NPi values during CPR can indicate a progressive oxygenation and functionality of tissues with an increased probability of ROSC
Variable because depends on the cardiac resuscitation manoeuvers lasting usually not more than 45 minutes
Correlation between NPi trend and mRS in ROSC patients
Time Frame: 1 month, 6 months, 1 year

Similarly to outcome 4, we suppose that a progressive improvement of NPi values during CPR may suggest vitality of the brainstem and oxigenation of the brain.

We want to evaluate possible correlation between changing in NPi trend and neurological outcome with mRS in the survivors patient (ROSC)

1 month, 6 months, 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Simone M Zerbi, MD, ASST Lariana Ospedale Sant'Anna di Como
  • Study Director: Frank A Rasulo, Prof., Division of Anesthesiology, Intensive Care & emergency Medicine, Università degli studi di Brescia
  • Study Chair: Marco Botteri, MD, AREU - Agenzia Regionale Emergenza Urgenza
  • Study Chair: Claudio Sandroni, Prof., Institute of Anesthesiology and Intensive Care Medicine, Università Cattolica del Sacro Cuore, Roma.
  • Study Chair: Giovanni Chiarini, MD, Dip. Anestesia, Rianimazione ed Emergenze II, ASST Spedali Civili di Brescia
  • Study Chair: Maurizio Raimondi, MD, UOC Anestesia e Rianimazione Voghera e Oltrepò, ASST Pavia.
  • Study Chair: Antonio Bellasi, phD, Department of Medicine, Division of Nephrology, EOC, Lugano

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

December 1, 2022

Primary Completion (ANTICIPATED)

July 1, 2023

Study Completion (ANTICIPATED)

December 15, 2023

Study Registration Dates

First Submitted

November 25, 2021

First Submitted That Met QC Criteria

December 30, 2021

First Posted (ACTUAL)

January 14, 2022

Study Record Updates

Last Update Posted (ACTUAL)

October 26, 2022

Last Update Submitted That Met QC Criteria

October 25, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2494

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Subscribe